Early Detection and Prevention
Innovation: Therapeutics – anticancer system capable of loco-regional delivery of drug product
Targeted Cancer(s): Solid Tumors, Mucosal Cancers. Initial indication: Oral Cancer
Scientific Leadership/Leadership: Manijeh Goldberg, PhD., President & CEO; James Mackay, PhD., Board Member and Chief Advisor; Nishant Agrawal, MD., Chief Medical Advisor
Stage…
Developing appropriate models for diseases such as cancer and Alzheimer’s disease is critical for dissecting their disease…
Esophageal cancer (EC) is one of the most deadly cancers worldwide, with five –year survival rates of only around 10%…
Understanding the risk of breast cancer in the Chinese population is very important due to the exponential increase in incidence…
Developing reliable biomarkers for predicting the risk of metastasis/recurrence for individual colorectal cancer patients
Identifying Biomarkers of Esophageal Cancer: Developing a Screening Test for Early Detection To Improve Survival